Evaluation of Pancreatic Injury in COVID-19 Patients: A Single Center Retrospective Study

Aim: Pancreatic injury has become a significant complication linked to COVID-19 infection. Our study's aim was to compare the clinical and laboratory findings, intensive care requirements, and mortality rates between patients with and without pancreatic enzyme elevation among those diagnosed with COVID-19. Material and Method: The retrospective investigation was carried out at a tertiary hospital and involved PCR-confirmed COVID-19 patients. Data from 457 participants was collected, and 376 eligible participants were analyzed using statistical methods. Patients with amylase or lipase levels up to three times normal were classified as having pancreatic injury, while those with normal levels were the control group. Mann-Whitney U test was utilized for group comparisons. Factors predicting intensive care unit (ICU) admission were identified using logistic regression analysis; p